Titan Pharmaceuticals, Inc. Total Assets
Titan Pharmaceuticals, Inc. had Total Assets of $3.05 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-08-14
- 2025-06-30: Assets $3.05M.
- 2025-03-31: Assets $2.16M.
- 2024-12-31: Assets $2.92M.
- 2024-09-30: Assets $3.60M.
| Period end | Assets |
|---|---|
| 2025-06-30 | $3.05M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.16M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.92M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $3.60M 10-Q · filed 2025-01-03 |
| 2024-06-30 | $4.35M 10-Q · filed 2024-08-15 |
| 2024-03-31 | $6.65M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.09M 10-K · filed 2025-03-20 |
| 2023-09-30 | $10.00M 10-K · filed 2024-04-01 |
| 2023-06-30 | $812.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.17M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $4.06M 10-K · filed 2024-04-01 |
| 2022-09-30 | $6.28M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.32M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.32M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.99M 10-K · filed 2023-03-31 |
| 2021-09-30 | $9.64M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $11.51M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $13.82M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $8.09M 10-K · filed 2022-03-25 |
| 2020-09-30 | $8.02M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $9.76M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $13.26M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $9.52M 10-K · filed 2021-03-31 |
| 2019-09-30 | $5.30M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $6.76M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $11.44M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $14.10M 10-K · filed 2020-03-30 |
| 2018-09-30 | $11.85M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $4.62M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $5.29M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.90M 10-K/A · filed 2019-04-02 |
| 2017-09-30 | $12.74M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $9.41M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $13.07M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $18.67M 10-K · filed 2018-04-02 |
| 2016-09-30 | $23.54M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $25.30M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $12.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $13.29M 10-K · filed 2017-03-16 |
| 2015-09-30 | $14.91M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $17.31M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $18.39M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $20.85M 10-K · filed 2016-03-15 |
| 2014-09-30 | $13.22M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $14.25M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $16.12M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $18.42M 10-K · filed 2015-03-31 |
| 2013-09-30 | $15.52M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $16.91M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $23.53M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $24.83M 10-K · filed 2014-03-31 |
| 2012-09-30 | $10.74M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $10.05M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $7.51M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $10.22M 10-K · filed 2013-03-18 |
| 2011-09-30 | $6.55M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $8.84M 10-Q/A · filed 2011-08-17 |
| 2010-12-31 | $4.75M 10-K · filed 2012-03-15 |